Esperion Therapeutics, Inc. - Common Stock (NQ:ESPR)

3.180 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Esperion Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Esperion Therapeutics: Q2 Earnings Insights ↗

August 02, 2022

Esperion Therapeutics (NASDAQ:ESPR) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 24, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 06, 2022

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022 ↗

May 05, 2022

Upgrades

Via Benzinga

Esperion Therapeutics: Q1 Earnings Insights ↗

May 03, 2022

Esperion Therapeutics (NASDAQ:ESPR) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 22, 2022 ↗

February 22, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Following Wednesday's Surge ↗

May 05, 2022

Pre-open movers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Esperion Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 21, 2022

Esperion Therapeutics (NASDAQ:ESPR) will host a conference call at 08:00 AM ET on May 3, 2022, to discuss Q1 2022 earnings results. How to Attend Esperion Therapeutics (ESPR) Conference Call Follow...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 14, 2022

Gainers Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their outstanding shares is at $48.1 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022 ↗

March 10, 2022

Upgrades For Alpha Metallurgical Resources Inc (NYSE:AMR), B. Riley Securities upgraded the previous rating of Neutral to Buy. For the fourth quarter, Alpha Metallurgical...

Via Benzinga

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 22, 2022

Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,...

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

February 22, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...

Via Benzinga

Recap: Esperion Therapeutics Q4 Earnings ↗

February 22, 2022

Esperion Therapeutics (NASDAQ:ESPR) reported its Q4 earnings results on Tuesday, February 22, 2022 at 07:00 AM. Here's what investors need to know about the...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

December 09, 2021

SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE:

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

December 06, 2021

Cowen & Co. raised the price target on The Boston Beer Company, Inc. (NYSE:

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 07, 2022

On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...

Via Benzinga

Charms Of China ↗

December 03, 2021

Today the global stock market rout was pretty awful.

Via Talk Markets

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

58 Biggest Movers From Friday ↗

December 06, 2021

Gainers Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62. TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30. IO Biotech, Inc. (NASDAQ: IOBT) shares...

Via Benzinga

Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb ↗

December 03, 2021

Toward the end of trading Friday, the Dow traded down 0.37% to 34,512.05 while the NASDAQ fell 2.28% to 15,029.99. The S&P also fell, dropping 1.13% to 4,525.40. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 03, 2021

Gainers Celyad Oncology (NASDAQ:CYAD) stock moved upwards by 32.58% to $4.72 during Friday's regular session. Trading volume for this security as of 12:30 EST is 45.2...

Via Benzinga

Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings ↗

December 03, 2021

Midway through trading Friday, the Dow traded down 0.77% to 34,373.98 while the NASDAQ fell 2.8% to 14,950.19. The S&P also fell, dropping 1.52% to 4,507.37. The U.S. has the...

Via Benzinga

Topics Stocks

41 Stocks Moving In Friday's Mid-Day Session ↗

December 03, 2021

Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to...

Via Benzinga

Topics Initial Public Offering

Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast ↗

December 03, 2021

Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65. The...

Via Benzinga

Topics Stocks

Esperion Shares Fall After $225M Capital Raise Via Equity ↗

December 03, 2021

Esperion Therapeutics Inc (NASDAQ: ESPR) priced its previously announced underwritten public offering of 32.14 million shares and short-term warrants to purchase up to 32.14...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 03, 2021

Gainers Celyad Oncology (NASDAQ:CYAD) shares rose 22.75% to $4.37 during Friday's pre-market session. The company's market cap stands at $70.3 million. Biolase (...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.